Kazunori Kawamura1、Katsushi Kumata1、Masanao Ogawa1,2、Yusuke Kurihara1,2、Nobuki Nengaki1,2、Tomoteru Yamasaki1、Yukimi Nakamura3、Maiko Ono4、Yuhei Takado4、Hironaka Igarashi3、Ming-Rong Zhang1 (1.Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology, Chiba, Japan、2.SHI Accelerator Service Ltd., Tokyo, Japan、3.Brain Research Institute, Niigata University, Niigata, Japan、4.Institute for Quantum Life Science, National Institutes for Quantum Science and Technology, Chiba, Japan)
Session information
[JSNM]Oral
Annual Scientific Meeting of the Japanese Society of Nuclear Medicine Program » 一般演題
Oral 19:Pharmaceutical Synthesis・Quality Control 1
Thu. Nov 7, 2024 2:25 PM - 3:15 PM Room 7 (3F 304, Conference Center, PACIFICO Yokohama)
座長:川井 恵一(金沢大学 医薬保健研究域・保健学系)、加川 信也(滋賀県立総合病院 臨床研究センター)
Tetsuro Tago1、Jun Toyohara1、Hiroshi Tanaka2 (1.Research Team for Neuroimaging, Tokyo Metropolitan Institute for Geriatrics and Gerontology, Tokyo, Japan、2.Faculty of Pharmacy, Juntendo University, Tokyo, Japan)
Toshimitsu Okamura1、Tatsuya Kikuchi1、Masanao Ogawa1,2、Ming-Rong Zhang1 (1.National Institutes for Quantum Science and Technology, Chiba, Japan、2.SHI Accelerator Service Ltd, Tokyo, Japan)
Masayuki Hanyu1、Lin Xie1、Yiding Zhang1、Ayumi Kadoma1、Hisashi Suzuki1、Kotaro Goto2、Masako Mori2、Mamoru Mizuno2、Ming-Rong Zhang1 (1.Department of Advanced Nuclear Medicine Sciences, Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology, Chiba, Japan、2.The Noguchi Institute, Tokyo, Japan)
Jun Toyohara、Tetsuro Tago、Muneyuki Sakata (Research Team for Neuroimaging, Tokyo Metropolitan Institute for Geriatrics and Gerontology)